Total Funding
46
49
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
84708
Aytu BioPharma is a specialty healthcare company focused on developing treatments for urological and related conditions.
Jarrett Disbrow: Executive Vice President, Corporate OperationsPast Role: Arbor Pharmaceuticals, Founder, President and Chief Executive Officer- Ryan Selhorn: CFO
About the Company
Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu BioScience is initially concentrating on male sexual dysfunction and male infertility and will seek expansion opportunities in other urological indications.
